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The choice of medication for patients with bipolar disorder Of 60 patients with depressive episode, 7 were given single MS and 6 were given single AAp. 42 were given one AAP and one MS. 2 were given one AAP and two MS. 11 were given two AAP and one MS. 1 was given two AAP and two MS. Of 110 patients with manic episode, 3 were given single MS and 4 were given single AAp. 76 were given one AAP and one MS. 6 were given two AAp. 8 were given one AAP and two MS. 10 were given two AAP and one MS. 3 were given more than two AAP and two MS. Discussion: Our 6 year analysis revealed no differences between AAP (8.7%) and MS (10.1%) as monotherapy. Antidepressants were never used in monotherapy, possibly due to mood switches. In both manic and depressive bipolar patients, the combination therapy of one MS and one AAP was the vast majority (60.9%). This analysis shows that most times, monotherapy isn't enough to treat the patient and doctors often have to resort to combination therapy.
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Psychiatrists' thinking about how to prescribe psychotropic drugs in out-patients with major depressive disorder and bipolar disorder in general clinical practice compared to the evidence-based guidelines.
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Abstract Objective: The purposes of this study were to compare the differences between the evidence-based guidelines and real psychiatrists' prescriptions on patients with major depressive disorder (MDD) and bipolar disorder (BD), and to survey psychiatrist's thinking about how to prescribe psychotropic drugs in patients with MDD and BD in general clinical practice. Methods: This study was cross-sectional design. We investigated antipsychotics, antidepressants, mood stabilizers, and benzodiazepines for out-patients with MDD and BD type I and II. We compared real prescriptions to the three latest guidelines, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative guideline, the World Federation of Societies of Biological Psychiatry (WFSBP) guidelines and guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders. We collected clinical data including mood states such as mania/ hypomania, depression, or remission at the investigation time, and the questionnaires to assess the reason that psychiatrists prescribed each psychotropic drug to the patients. Among psychotropic Results: We examined 118 patients with MDD and 211 patients with BD (type I, 62; type II, 149) at Chiba University Hospital for June and July 2013. Most of the medications prescribed for BD were those recommended in the guidelines (antidepressants, mood stabilizers, and antipsychotics). Unlike in the guidelines, lamotrigine was prescribed for 17.5% (n = 7/40) bipolar patients with mixed or hypomanic state to expect prevention of future depressive episode and for 13.8% (n = 8/58) patients with MDD to expect antidepressant effect. Low dose of aripiprazole was also prescribed for 10% (n = 8/80) bipolar patients with depressive state to expect improvement of depressive symptoms. Conclusion: This study demonstrated some of psychotropic drugs were prescribed for current symptoms and future expected episodes.
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The protective effects of hypomanic symptoms in a major depressive episode on suicide attempt in bipolar disorder
